Molecular insights: Detecting gene fusions offers new avenues for advanced cancer management

FHS
August 8, 2023
10:13 am

Study identifies gene fusions to understand their relationship with observed pathologies in cancer patients.

Pfizer’s Elrexfio tries to challenge Janssen in RRMM with FDA approval – Pharmaceutical Technology

Elrexfio is currently under review for marketing approval in Switzerland, Brazil, Canada, Australia, the EU, Japan and Singapore. Credit: Molly Woodward / Shutterstock. Pfizer’s Elrexfio

August 15, 2023

Opinion | The Project 2025 Promise: Worse Health and Climate Chaos

Zigmund is an associate professor of clinical radiology. Climate change increasingly threatens health and financial well-being. Nearly 8 million acres in the U.S. have burned

October 9, 2024

Opinion | Flipping Panel Management on Its Head

Fred Pelzman is an associate professor of medicine at Weill Cornell, and has been a practicing internist for nearly 30 years. He is medical director

October 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.